1383 related articles for article (PubMed ID: 33931597)
21. IGF2BP3-NRF2 axis regulates ferroptosis in hepatocellular carcinoma.
Lu Z; Yang H; Shao Y; Sun W; Jiang Y; Li J
Biochem Biophys Res Commun; 2022 Oct; 627():103-110. PubMed ID: 36030651
[TBL] [Abstract][Full Text] [Related]
22. GSTZ1-1 Deficiency Activates NRF2/IGF1R Axis in HCC via Accumulation of Oncometabolite Succinylacetone.
Yang F; Li J; Deng H; Wang Y; Lei C; Wang Q; Xiang J; Liang L; Xia J; Pan X; Li X; Long Q; Chang L; Xu P; Huang A; Wang K; Tang N
EMBO J; 2019 Aug; 38(15):e101964. PubMed ID: 31267557
[TBL] [Abstract][Full Text] [Related]
23. CircIL4R facilitates the tumorigenesis and inhibits ferroptosis in hepatocellular carcinoma by regulating the miR-541-3p/GPX4 axis.
Xu Q; Zhou L; Yang G; Meng F; Wan Y; Wang L; Zhang L
Cell Biol Int; 2020 Nov; 44(11):2344-2356. PubMed ID: 32808701
[TBL] [Abstract][Full Text] [Related]
24. DN200434, an orally available inverse agonist of estrogen-related receptor γ, induces ferroptosis in sorafenib-resistant hepatocellular carcinoma.
Kim DH; Kim MJ; Kim NY; Lee S; Byun JK; Yun JW; Lee J; Jin J; Kim J; Chin J; Cho SJ; Lee IK; Choi YK; Park KG
BMB Rep; 2022 Nov; 55(11):547-552. PubMed ID: 36016501
[TBL] [Abstract][Full Text] [Related]
25. Naringenin alleviates myocardial ischemia/reperfusion injury by regulating the nuclear factor-erythroid factor 2-related factor 2 (Nrf2) /System xc-/ glutathione peroxidase 4 (GPX4) axis to inhibit ferroptosis.
Xu S; Wu B; Zhong B; Lin L; Ding Y; Jin X; Huang Z; Lin M; Wu H; Xu D
Bioengineered; 2021 Dec; 12(2):10924-10934. PubMed ID: 34699317
[TBL] [Abstract][Full Text] [Related]
26. 1,25(OH)
Cheng K; Huang Y; Wang C
Int J Mol Sci; 2021 Oct; 22(21):. PubMed ID: 34768761
[TBL] [Abstract][Full Text] [Related]
27. Silencing lncRNA HCG18 regulates GPX4-inhibited ferroptosis by adsorbing miR-450b-5p to avert sorafenib resistance in hepatocellular carcinoma.
Li X; Li Y; Lian P; Lv Q; Liu F
Hum Exp Toxicol; 2023; 42():9603271221142818. PubMed ID: 36786348
[TBL] [Abstract][Full Text] [Related]
28. SIRT6 silencing overcomes resistance to sorafenib by promoting ferroptosis in gastric cancer.
Cai S; Fu S; Zhang W; Yuan X; Cheng Y; Fang J
Biochem Biophys Res Commun; 2021 Nov; 577():158-164. PubMed ID: 34530350
[TBL] [Abstract][Full Text] [Related]
29. Activation of the p62-Keap1-NRF2 pathway protects against ferroptosis in hepatocellular carcinoma cells.
Sun X; Ou Z; Chen R; Niu X; Chen D; Kang R; Tang D
Hepatology; 2016 Jan; 63(1):173-84. PubMed ID: 26403645
[TBL] [Abstract][Full Text] [Related]
30. Epigenetic regulation of ferroptosis via ETS1/miR-23a-3p/ACSL4 axis mediates sorafenib resistance in human hepatocellular carcinoma.
Lu Y; Chan YT; Tan HY; Zhang C; Guo W; Xu Y; Sharma R; Chen ZS; Zheng YC; Wang N; Feng Y
J Exp Clin Cancer Res; 2022 Jan; 41(1):3. PubMed ID: 34980204
[TBL] [Abstract][Full Text] [Related]
31. Hypermethylation of the Nrf2 Promoter Induces Ferroptosis by Inhibiting the Nrf2-GPX4 Axis in COPD.
Zhang Z; Fu C; Liu J; Sai X; Qin C; Di T; Yang Y; Wu Y; Bian T
Int J Chron Obstruct Pulmon Dis; 2021; 16():3347-3362. PubMed ID: 34934311
[TBL] [Abstract][Full Text] [Related]
32. ABCC5 facilitates the acquired resistance of sorafenib through the inhibition of SLC7A11-induced ferroptosis in hepatocellular carcinoma.
Huang W; Chen K; Lu Y; Zhang D; Cheng Y; Li L; Huang W; He G; Liao H; Cai L; Tang Y; Zhao L; Pan M
Neoplasia; 2021 Dec; 23(12):1227-1239. PubMed ID: 34768109
[TBL] [Abstract][Full Text] [Related]
33. Overcoming the compensatory elevation of NRF2 renders hepatocellular carcinoma cells more vulnerable to disulfiram/copper-induced ferroptosis.
Ren X; Li Y; Zhou Y; Hu W; Yang C; Jing Q; Zhou C; Wang X; Hu J; Wang L; Yang J; Wang H; Xu H; Li H; Tong X; Wang Y; Du J
Redox Biol; 2021 Oct; 46():102122. PubMed ID: 34482117
[TBL] [Abstract][Full Text] [Related]
34. Ferroptosis is induced by lenvatinib through fibroblast growth factor receptor-4 inhibition in hepatocellular carcinoma.
Iseda N; Itoh S; Toshida K; Tomiyama T; Morinaga A; Shimokawa M; Shimagaki T; Wang H; Kurihara T; Toshima T; Nagao Y; Harada N; Yoshizumi T; Mori M
Cancer Sci; 2022 Jul; 113(7):2272-2287. PubMed ID: 35466502
[TBL] [Abstract][Full Text] [Related]
35. RSL3 Drives Ferroptosis through NF-
Li S; He Y; Chen K; Sun J; Zhang L; He Y; Yu H; Li Q
Oxid Med Cell Longev; 2021; 2021():2915019. PubMed ID: 34987700
[TBL] [Abstract][Full Text] [Related]
36. Melatonin improves hypoxic-ischemic brain damage through the Akt/Nrf2/Gpx4 signaling pathway.
Gou Z; Su X; Hu X; Zhou Y; Huang L; Fan Y; Li J; Lu L
Brain Res Bull; 2020 Oct; 163():40-48. PubMed ID: 32679060
[TBL] [Abstract][Full Text] [Related]
37. Interventing mitochondrial PD-L1 suppressed IFN-γ-induced cancer stemness in hepatocellular carcinoma by sensitizing sorafenib-induced ferroptosis.
Li T; Huang HY; Qian B; Wang WH; Yuan Q; Zhang HY; He J; Ni KJ; Wang P; Zhao ZY; He JL; Fu SW; Xu L; Lin YC; Lin ZN
Free Radic Biol Med; 2024 Feb; 212():360-374. PubMed ID: 38171407
[TBL] [Abstract][Full Text] [Related]
38. The induction of ferroptosis by impairing STAT3/Nrf2/GPx4 signaling enhances the sensitivity of osteosarcoma cells to cisplatin.
Liu Q; Wang K
Cell Biol Int; 2019 Nov; 43(11):1245-1256. PubMed ID: 30811078
[TBL] [Abstract][Full Text] [Related]
39. Metallothionein-1G facilitates sorafenib resistance through inhibition of ferroptosis.
Sun X; Niu X; Chen R; He W; Chen D; Kang R; Tang D
Hepatology; 2016 Aug; 64(2):488-500. PubMed ID: 27015352
[TBL] [Abstract][Full Text] [Related]
40. Ibuprofen induces ferroptosis of glioblastoma cells via downregulation of nuclear factor erythroid 2-related factor 2 signaling pathway.
Gao X; Guo N; Xu H; Pan T; Lei H; Yan A; Mi Y; Xu L
Anticancer Drugs; 2020 Jan; 31(1):27-34. PubMed ID: 31490283
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]